Subject Index Vol. 77, 2006

Subject Index Vol. 77, 2006 Urologia Internationalis Adeno-associated virus 355 Adjuvant chemotherapy, upper urinary tract transitional cell carcinoma 22 Adrenal incidentaloma 173 Adrenalectomy 173 Age-standardized incidence rate, prostate cancer 311 Aggressive renal tumor 184 Aging male, erectile dysfunction 251 Androgen receptor antagonists 311 – suppression 135 Antibody basiliximax 232 Balkan endemic nephropathy 240 Benign neoplasm 281 – prostatic hyperplasia 159, 327 Biochemical recurrence 122, 200 – – after radical prostatectomy 130 Bladder cancer 13, 69, 81, 152, 245, 255, 355 – –, environmental risk factors 152 – hyperactivity 57 – outlet obstruction 76 – rupture 92 – stones 284 – tissues, CD10 expression 107 – tumor progression/recurrence 27 Bladder-sparing surgery 18 Blocked urethral catheter 317 Body mass index 114 Bone metastases 50, 184 Botryoid-type tumor 89 Buccal mucosa 368 Cambian layer 89 Camptothecin drug resistance 347 Catheterization complication 317 CD10 expression 107 Cerebral hypoperfusion, chronic 57 Chondrosarcoma 86 Chronic pelvic pain 227 – Prostatitis Symptom Index 227 Cisplatin 355 Complications 143 –, operative 216 C-reactive protein 127 Cryptorchidism 187, 264 Cystoprostatectomy 190 Cystoscopy 279 © 2006 S. Karger AG, Basel Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com Accessible online at: www.karger.com/uin Daily doses, LH-RH analogs/androgen receptor antagonists 311 Dermoid 279 – cyst 281 Diverticulum 368 Doppler sonography 170 Duplication of ureters 104 Ectopic 118 Endourology 362 Enteral nutrition 139 Erectile dysfunction 182, 251 Erythropoietin 211 Extended release formulation 334 Extracellular matrix components 255 Flank pain 286 Flow cytometry 275 Frozen section analysis 13 Gene therapy 355 Hand-assisted isthmectomy 94 HCl duloxetine 9 Hemorrhagic cystitis, morbidity 190 High-risk prostate cancer 122 Histopathological assessment 301 Horseshoe kidney 94 – – transplantation, long-term results 6 – –, surgical technique 6 Hydatid disease 371 Hypoxia-inducible factors (HIF-1␣, HIF-2␣) 255 Ileal conduit 245 Imaging 69 Immunohistochemistry 76, 255 Immunological monitoring 232 Incidentally found adrenal tumors 173 Interleukin-2 receptor 232 Intracorporeal lithotripsy 284 Intravesical explosion 92 Ischemia, forebrain 57 Kattan nomogram 222 Kidney calculi 340 – transplantation 6, 232 –, hydatidosis 371 Knotting of tube 317 Krimpen study 159 Laparoscopic left radical nephrectomy 94 Laparoscopy 118, 166, 190, 216 LH-RH analogs 311 Live-donor renal transplantation 42 Low-affinity nerve growth factor receptor 76 Lower urinary tract symptoms 251 Luteinizing hormone-releasing hormone agonist 135 Lymphoceles 42 Magnetic resonance imaging 301 Malignant transformation 86 Medullary carcinoma 184 Metaplasia, children 46 Metastases 127 Metastasis, nodal 64 Munchhausen syndrome 284 Neoadjuvant hormonal therapy 122 Nephrectomy 118 Non-invasive urodynamics 159 – –, volunteer recruitment 159 Normal voiding pattern 322 Operative failure 148 Overactive bladder 334 – –, treatment 327 p53 355 – nuclear accumulation, transitional papillary bladdercarcinoma 27 Paraurethral epidermoid cyst 187 Pelvic malignancy 18 Penile length 114 Percutaneous access point number and location 340 – nephrolithotomy 340 – –, complication rates 340 – –, success rates 340 Plasmakinetics 143 Pneumatic lithotripsy 148 Polymerase chain reaction 81 Positron emission tomography 69 Prazosin 269 Prescription practice, LH-RH analogs/ androgen receptor antagonists 311 Prevalence, overactive bladder 327 Priapism 182 Propiverine 334 Prostate 251 – cancer 50, 127, 135, 182, 200, 205, 211, 307, 311, 347 – – detection 301 – – status determination 307 – –, risk of recurrence 222 – growth, rats 269 Prostatectomy 130, 216, 222 Prostate-specific antigen 127, 130, 200 – – doubling time 205 – – level, elevated 222 Prostatic neoplasms 130, 216 Prostatitis 227 Protein profiling 347 Proteomics 347 Puberty 114 Pumpkin seed oil 269 Pyelolithotomy 118 Pyeloplasty 118 Radical cystectomy 13 – –, recovery 139 – cystoprostatectomy 307 – nephrectomy 166 – nephroureterectomy/regional lymphadenectomy 22 – prostatectomy 9, 182, 200, 205, 211 Radionuclide treatment 50 Radiotherapy 190 Recruitment, epidemiological aspects 159 Renal abnormality 6 – artery 170 – cell carcinoma 94, 166 – contusion 362 – hemorrhage 34 – medullary carcinoma 184 – pelvis tumor 89 – transplantation 104 Subject Index Retroperitoneal/transperitoneal approach 166 Retropubic radical prostatectomy 301 Rhabdomyosarcoma 89 Salvage radiotherapy 205 Salvia miltiorrhiza 275 Schiedam study 159 Selective embolization 362 Seminoma, testicular 64 Serum testosterone 135 Shock wave lithotripsy 179 Sickle cell trait 184 Sildenafil 170 Simple cyst vs. hydatid cyst 371 Single nucleotide polymorphism 81 Smoking 152 Solitary functioning kidneys 179 Spermatogenesis 275 Squamous metaplasia 46 Staging 69 Stent migration 297 Stents 42 Superselective catheterization 34 – embolization 34 Ta-T1 transitional cell carcinoma 152 Teratoma 86, 279 Testicular cancer 86 – cystic lesion 281 – hypotrophy 114 – torsion 275 Testis, dermoid cyst 281 Testosterone 269 Thymidine phosphorylase 255 Total parenteral nutrition 139 Transient hypothyroidism 264 Transitional cell carcinoma 69 – – –, upper urinary tract 22 – papillary bladder carcinoma 27 Transureteroureterostomy 245 Urol Int Vol. 77, 2006 Transurethral resection 216 – – of prostate 92, 143 Undescended testes 264 Upper urothelial tumor 240 Ureteral herniation 286 – margin 13 Ureteric stent 297 – stenting, shock wave lithotripsy 179 Ureterocutaneostomy 245 Ureterolysis 286 Ureteroneocystostomy 42 Ureteroscopy 148 Urethral polyp 187 Urethroplasty 368 Urge incontinence 327 Urinary bladder 46 – catheter 317 – continence 216 – diversion 245 – reconstruction 104 – tract infection 327 Urinoma 362 Urodynamics 9 Urokinase 81 Urolithiasis 284 Urological complications 42 – emergency 317 Urothelial bladder carcinomas 107 Varicocele 114 Vascular endothelial growth factor 255 Ventral onlay 368 Verumontanum 187 Voiding diary 322 Volume-frequency chart 322 379